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Abstract
Background: Peste des petits ruminants (PPR) is an economically important, Office International des Epizooties (OIE)
notifiable, transboundary viral disease of small ruminants such as sheep and goat. PPR virus (PPRV), a negative-sense
single-stranded RNA virus, is the causal agent of PPR. Therefore, sensitive, specific and rapid diagnostic assay for the
detection of PPRV are necessary to accurately and promptly diagnose suspected case of PPR.
Methods: In this study, reverse transcription recombinase polymerase amplification assays using real-time fluorescent
detection (real-time RT-RPA assay) and lateral flow strip detection (LFS RT-RPA assay) were developed targeting the N
gene of PPRV.
Results: The sensitivity of the developed real-time RT-RPA assay was as low as 100 copies per reaction within 7 min at
40 °C with 95% reliability; while the sensitivity of the developed LFS RT-RPA assay was as low as 150 copies per reaction
at 39 °C in less than 25 min. In both assays, there were no cross-reactions with sheep and goat pox viruses, foot-and-
mouth disease virus and Orf virus.
Conclusions: These features make RPA assay promising candidates either in field use or as a point of care diagnostic
technique.
Keywords: Reverse transcription recombinase polymerase amplification assay, RT-RPA, Lateral flow strip, PPRV, Small
ruminants
Background
Peste des petits ruminants (PPR) is one of the most con-
tagious diseases of small ruminants, which remains
endemic in most of Africa, the Middle East, South Asia
and China [1–3]. With morbidity and mortality rates as
high as 90%, PPR has a devastating impact on the liveli-
hood of the poor and marginal farmers in endemic
countries. After the successful global rinderpest eradica-
tion program in cattle, PPR has emerged as one of the
priority animal diseases whose global control and
eradication for poverty alleviation should be considered.
To achieve this goal, rapid and accurate diagnosis of
PPR would be of important and highly demanded.
The causative agent, PPR virus (PPRV) is a representative
member of the genus Morbillivirus of the family Paramyxo-
viridae. PPRV has a genome length of 15,948 nucleotides,
which contains six transcriptional units that encode six
contiguous and non-overlapping proteins [4]. Genes in
PPRV are arranged in an order of 3′-N-P/C/V-M-F-HN-L-
5′ [5] and each gene is separated by an intergenic region of
variable lengths [6]. Like other negative stranded RNA
viruses, the genomic RNA is packaged by nucleoprotein
(N) to form nucleocapsid along with phosphoprotein (P)
and large protein (L). N protein is a major viral protein
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produced in highest amount in Morbilliviruses. Based
on the N gene, PPRV isolates can be divided into 4 dis-
tinct lineages, i.e. lineages I and II only occur in Africa,
lineages III occur in Africa and Middle East, and the
fourth exists in both Africa and Asia [1, 5]. N protein
has been also extensively used in the development of
assays for diagnosis of PPR.
Based on clinical signs, PPR may be confused with
other diseases, such as capripox, foot-and-mouth dis-
ease and Orf, which also affect small ruminants.
Therefore, laboratory tests must be performed for a
definitive diagnosis of PPR. Different cell lines have
been used to isolate PPRV but with limited success
[7, 8]. Thus, an ELISA for detection of viral nucleo-
protein was developed as an alternative method to
virus isolation [9]. However, these methods are labori-
ous and time-consuming, and may not be used as
pen-side tests. Recently, an immunochromatographic
assay was developed for rapid detection of PPRV,
however, its sensitivity was not good enough to detect
PPRV in clinical samples with a low virus load [10].
Detection of serum antibody is also not effective be-
cause all assays based on detection of PPRV antibody
could not differentiate infected animals from vacci-
nated animals [11–13]. As a result of its rapid, accur-
ate, and sensitive nature, conventional reverse
transcription polymerase chain reactions (RT-PCRs)
are widely used for detection of PPRV genomic ma-
terial [14, 15]. However, these conventional RT-PCR
assays also have shortcomings, such as being labor in-
tensive, time consuming and high risk of cross-
contamination [16]. Real time RT-PCR assay has ac-
quired extensive adoption over conventional RT-PCR
and been developed for detection and quantitation of
PPRV present in clinical samples [16–20]. But the
real time RT-PCR assay still relies on specialized and
expensive thermos cycling machine, as a result it is
difficult to be used as a “pen-side” test and in en-
demic areas with low resources. Loop-mediated iso-
thermal amplification (LAMP) provides an isothermal
method to amplify viral RNA without requirement of
a specific thermal cycler. The LAMP reaction could
be performed using a water bath, and the reaction re-
sults could be directly distinguished through color
change by the naked eye. LAMP could adapt into dif-
ferent formats for detection of amplified products,
such as agarose gel, lateral flow analysis (visual moni-
toring) and real-time fluorescence analysis [21, 22].
However, RT-LAMP assay requires six primers and
has unsatisfactory reliability in detection of highly
variable viruses [21]. In recent years, a recombinase
polymerase amplification (RPA) assay was developed
for rapid detection of different viruses of veterinary
importance, such as foot-and-mouth disease virus
(FMDV) [23], Orf virus (ORFV) [24], Schmallenberg
virus (SBV) and bovine viral diarrhea virus (BVDV)
[21]. These studies had shown that RPA assay was
characterized with high sensitivity, good diagnostic
specificity and rapidity, and represents a powerful po-
tential to be a pen-side assay for rapid detection of
pathogens. The amplification of RPA relies on a spe-
cific combination of recombinase, single strand bind-
ing protein, and strand displacing DNA polymerase.
Twist Amp® exo probe is needed in real-time fluores-
cent probe-based RPA assay, in which generation of
fluorescence signal relies on the detaching off fluoro-
phore and quencher at an internal abasic site mimic
(tetrahydrofuran, THF) of the Twist Amp® exo-probe
using DNA repair enzyme Exonuclease III. The real-
time fluorescence signal is measured using fluores-
cence detection equipment. For lateral-flow strip
(LFS) based RPA assay, Twist Amp® nfo probe is
required. In the present study, reverse transcription
RPA assays with real-time fluorescent detection (real-
time RT-RPA assay) and lateral-flow strip detection
(LFS RT-RPA assay) were developed based on the N
gene of PPRV. The results showed that both PPRV
real-time and LFS RT-RPA assays developed are sensi-
tive and specific for detection of PPRV.
Methods
Virus strains
All viruses used in this study were preserved in our
laboratory: peste des petits ruminants virus (PPRV)
Nigeria 75/1; Orf virus (ORFV)/Vaccine/CHA; goat
pox viruses (GPV) AV40, sheep pox viruses (SPV)
Gulang2009; foot-and-mouth disease virus (FMDV)/
O/CHA; FMDV/A/CHA and FMDV/Asia I/CHA.
Sample preparation
To prepare PPRV-spiked tissues lysates, PPRV-free
tissues samples of liver, lungs, stomach, kidney,
lymphatic nodes and skin (n = 18, three each tissue)
were collected from three healthy sheep. 10% (w/v)
tissue suspensions (one milligram tissue samples were
homogenized with nine volumes PBS using MP
FastPrep-24) were then prepared by homogenizing tis-
sue samples in PBS. Following a brief centrifugation,
the homogenized tissue samples were spiked with 104
TCID50 of PPRV Nigeria 75/1 and stored at -80 °C
until used. Known PPRV positive samples (n = 14)
and known negative samples (n = 10) stored in our la-
boratory were confirmed using a real time RT-qPCR
assay [19]. Thirty-two clinical samples collected from
suspected cases of PPR in Gansu Province, China and
five samples obtained from healthy sheep, which were
screened with the RT-qPCR assay to confirm the
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presence or absence of PPRV-RNA, were also tested
using the newly developed RT-RPA assay.
Viral RNA extraction
Total RNA was extracted from samples using High Pure
Viral Nucleic Acid kit (Roche) according to the manu-
facturer’s instructions and eluted in a final volume of
40 μL. Extracted RNA was stored at -80 °C until further
use for all assays in this study.
Generation of RNA standard
The PPRV N gene segments (354 bp, ranging from
528 bp to 881 bp of X74443) were synthesized by Gene-
wiz (Suzhou, China) and cloned into a pUC57 vector
downstream of the T7 promoter, designated as pPPRV/
RPA. The pPPRV/RPA plasmid was extracted using Plas-
mid Mini kit I (Promega, USA) and the plasmid was lin-
earized downstream of the PPRV N gene segments. A
total of 1 μg of linearized product was used for in vitro
transcription (Megascript® kit, Ambion, USA) following
the manufacturer’s instructions. Transcribed RNA was
DNase treated and purified using an RNA clean-up
protocol (RNeasy Mini KIT, Qiagen, Germany) accord-
ing to the manufacturer’s instructions. The purified
RNA was quantified by Nanovue (GE lifescience, USA)
and stored at -80 °C until used.
Primers and probe design and optimizing for RPA
PPRV-specific RPA primers and probe, based on the N
gene of PPRV, were designed according to RPA guide-
lines (Twist Amp® DNA amplification kits combined in-
struction manual) from TwistDx (Cambridge, United
Kingdom). Primers and probe were aligned with the N
gene consensus sequence of X74443 (LII, Nigeria),
L39878 (LII, Nigeria), EU267274 (LII, Nigeria),
EU267273 (LI, Cote d’Ivoire), AJ849636 (LIV, Turkey),
FJ905304 (LIV, China Tibet), AY560591 (LIV, India Sun-
gri), AJ563705 (LIV, Turkey), KJ867543 (LIII, Uganda)
and KJ867544 (LIII, Oman). All PPRV N gene sequences
above were retrieved from GenBank and multiple se-
quence alignment of the gene sequences were manually
designed based on the PPRV N gene as recommendation
by TwistDx (Cambridge, UK). All primers and probes were
synthesized by Sangon Biotech (Shanghai, China). The se-
quences of all the primers and probe were shown in Table 1.
In order to determine the most efficient primer pair for
PPRV real-time RT-RPA assay, three forward primers (Fe1
N to Fe3 N) and reverse primers (Re1 N to Re3 N) target-
ing different regions of N gene were designed based on the
alignment of all available sequences of PPRV N gene
(Table 1). Nine different combinations of primers (i.e. Fe1
N/Re1 N; Fe1 N/Re2 N; Fe1 N/Re3 N; Fe2 N/Re1 N; Fe2
N/Re2 N; Fe2 N/Re3 N; Fe3 N/Re1 N; Fe3 N/Re2 N; Fe3
N/Re3 N) were then tested with the probe (Pe) in the PPRV
real-time RT-RPA assay.
Table 1 RPA primers and probes designed in this study
Name Sequence (5′–3′) Genome location(X74443)
PPRV-RPA Fe1 N GAAGAGTTCAATATGTTGTTAGCCTCCAT 588–616
PPRV-RPA Fe2 N CCAAGGCGGTTACGGCACCGGATACGGCAGCTGAC 643–677
PPRV-RPA Fe3 N TTACGGCACCGGATACGGCAGCTGACTCAGAACTG 652–686
PPRV-RPA Re1 N TTTGTCAAGGCGAAATTCCCCAATCACTCTCC 715–746
PPRV-RPA Re2 N ACTGCGTCCAGCCACCCTTTGTCAAGGCGAAATTC 729–763
PPRV-RPA Re3 N ACTGCGTCCAGCCACCCTTTGTCAAGGCGAAA 732–763
PPRV-RPA Pe GATACGGCAGCTGACTCAGAACTGAGAAGG
(FAM-dT)G(THF)G(BHQ1-dT)TAAATACACACAACA - C3 space
663–712
PPRV-RPA Fn1 N GAAGAGTTCAATATGTTGTTAGCCTCCAT 588–616
PPRV-RPA Fn2 N CCAAGGCGGTTACGGCACCGGATACGGCAGCTGAC 643–677
PPRV-RPA Fn3 N TTACGGCACCGGATACGGCAGCTGACTCAGAACTG 652–686
PPRV-RPA Rn1 N Biotin-TTTGTCAAGGCGAAATTCCCCAATCACTCTCC 715–746
PPRV-RPA Rn2 N Biotin-ACTGCGTCCAGCCACCCTTTGTCAAGGCGAAATTC 729–763
PPRV-RPA Rn3 N Biotin-ACTGCGTCCAGCCACCCTTTGTCAAGGCGAAA 732–763
PPRV-RPA Pn FAM-TACGGCAGCTGACTCAGAACTGAGAAGGTG 663–712
-THF-GTTAAATACACACAA-C3 space
PPRV-RPA F and R, RPA primer; PPRV-RPA P, RPA Exo probe; BHQ1-dT, thymidine nucleotide carrying Black Hole Quencher 1; THF, tetrahydrofuran spacer; FAM-dT,
thymidine nucleotide carrying fluorescein; C3 space, block elongation; “F”, “R”, “N”, “P”, “e” and “n” were defined as forward primer, reverse primer, nucleoprotein,
probe, RPA exo kit and RPA nfo kit, respectively
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Real-time RT-qPCR assay
Real-time RT-qPCR assay was performed in Agilent
Technologies Stratagene Mx3005P thermocycler (Life
technologies, USA) using the Superscript III/Platinum
Taq One-step RT-qPCR kit (Invitrogen, USA) [19]. The re-
actions were prepared as a 25 μL reaction volume contain-
ing 2 μL extracted RNA, 12.5 μL Superscript III/Platinum
Taq One-step RT-qPCR reaction mix, 1 μL Superscript III/
Platinum Taq One-step RT-qPCR enzyme mix, 0.5 μL
ROX reference dye as a passive reference, 5 pmol Taqman
probe, and 10 pmol of forward and reverse primers. The
following thermal profile was used: an initial reverse tran-
scription at 45 °C for 30 min, followed at 95 °C for 10 min
and 40 cycles of amplification (15 s at 94 °C and 1 min at
60 °C). The data were analyzed using Mx3005P System
software.
Real-time RT-RPA assay
Real-time RT-RPA assay was performed in a 50 μL
volume using the Twist Amp® exo RT kit (TwistDx,
Cambridge, United Kingdom), which consisted of
29.5 μL rehydration buffer, 2 μL template RNA,
2.1 μL of forward and reverse primers (10 μM,
Beijing Genomics Institute, China), 0.3 μL of RPA
exo probe (10 μM, Sangon Biotech, China), 11.8 μL
of ddH2O and 2.5 μL of magnesium acetate
(280 mM). Optimal reaction conditions were defined
after testing different incubation temperatures (39 to
42 °C), as well as different concentrations of template
(0.5 μL to 2 μL) and magnesium acetate (1 μL to
2.5 μL). Fluorescence measurements using the FAM
channel were performed for 20 min at an optimized
temperature (40 °C). Fluorescence intensity of FAM
was determined every 20 s. A sample was deemed
positive if all replicates were three and a half stand-
ard deviations (3.5 SD) above the background during
a defined time range (i.e. after 19 to 20 min of amp-
lification). A threshold time range of 0 to 4 min and
30 s was used.
Lateral-flow strip RT-RPA assay
Lateral-flow strip RT-RPA assay (LFS RT-RPA assay)
was performed using the Twist Amp® nfo kit from
TwistDx (Cambridge, United Kingdom) according to
the manufacturer’s instruction. Briefly, the reverse pri-
mer with a 5′-biotin label was used. The probe con-
sists of an upstream stretch (30 bp) carrying a 5′-
FAM antigenic label, which is connected via a THF
spacer to an adjacent downstream oligonucleotide
(15 bp) carrying a C3-spacer (polymerase extension
blocking group) at its 3′end. All oligonucleotides in
this study were synthesized by Sangon Biotech
(Shanghai, China). The extracted PPRV RNA was first
reverse transcribed into cDNA before RPA reaction
was carried out with the Twist Amp® nfo kit, as the
kit did not contain reverse transcriptase. Synthesis of
cDNA was carried out in 20 μL reaction using tran-
scriptor first Strand cDNA Synthesis kit (Roche,
Germany) following manufacturer’s instructions.
Briefly, 1 μL anchored-oligo primer was added to
12 μL of the purified RNA. After incubation at 65 °C
for 10 min, the mixture was immediately placed on
ice for 2 min and a mixture containing 4 μL RT buf-
fer (5×), 0.5 μL Protector RNase inhibitor, 2 μL Deox-
ynucleotide Mix and 0.5 μL transcriptor reverse
transcriptase were added. The reaction was carried
out at 50 °C for 60 min and 85 °C for 5 min. PPRV
RPA nfo reactions were then performed in a 50 μL
volume with the Twist Amp® nfo kit (TwistDx, UK)
containing 420 nM nfo RPA primers, 15 nM RPA
probes, 2.5 μL of 280 mM MgAc, 2 μL of cDNA
template and 1× rehydration buffer. The RPA reaction
was carried out in the heating block at optimized
temperature (39 °C) for 20 min, and then Hybridetect
2 T lateral flow stripe (LFS) (Milenia Biotec GmbH,
Germany) dipsticks were used to detect amplicons.
One μL of the amplified product was diluted in
99 μL of the assay buffer (Tris-buffered saline). The
strips were then placed into the mixture and incu-
bated at an upright position. The final result was read
visually after incubation for 2 min at room
temperature. A testing sample was considered positive
when both the detection line (sample testing line)
and the control line (anti-rabbit antibody line) were
visible. A testing sample was considered negative
when only the control line was visible. The amplicons
could also been analyzed on 2% agarose-gel electro-
phoresis (Agarose Broad Range, Germany) stained
with ethidium bromide after being purified with PCR
clean-up Kit (Qiagen, Germany) to further confirm
the testing result.
Sensitivity and specificity of PPRV real time RT-RPA and
LFS RT-RPA assays
To test the dynamic range of PPRV real-time RT-
RPA assay, the standard RNA in vitro transcribed
from the pPPRV/RPA plasmid was diluted 10-fold
using ddH2O, ranging from 10
6 to 101 genome cop-
ies per reaction and then tested by PPRV real-time
RT-RPA assay. Every run was repeated six times. The
sensitivity of PPRV real-time RT-RPA assay was fur-
ther evaluated with spiked samples as described
above. The sensitivity of PPRV LFS RT-RPA assay
was determined by running 10-fold serial dilutions
(106 to 101 genome copies per reaction) of the stand-
ard RNA. Additionally, the amplified products in the
PPRV LFS RT-RPA reaction was also tested by subse-
quent visualization with agarose gel electrophoresis.
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The specificity of both PPRV real-time RT-RPA and
LFS RT-RPA assays were evaluated with FMDV sero-
types O, A and Asia 1, ORFV, GPV and SPV, which
caused similar clinical signs to PPR in small
ruminants.
Statistics analysis
The semi-log regression analyses of the sensitivity of
PPRV real time RT-RPA assay were performed using
PRISM 5.0 software (GraphPad Software, USA), and
the probit analysis were performed by Statistica soft-
ware (StatSoft, Hamburg, Germany). Comparison be-
tween values of real-time RT-RPA threshold time and
values of real-time RT-qPCR cycle threshold for PPRV
detection was performed by linear regression analysis
using Excel software.
Results
Sensitivity and specificity of PPRV real-time RT-RPA assay
The RT-RPA assay result showed that the primer set
Fe2 N/Re2 N yielded the highest efficiency of amplifi-
cation (Additional file 1: Figure S1). Therefore, this
pair of primers was employed in PPRV RT-RPA assay
for further validation. As shown in Fig. 1a, the dy-
namic detection range of the assay spans 5 logs ran-
ging from 6 to 2 log copies per reaction, with the
corresponding threshold time ranging from 3 min at
106 copies per reaction to 7 min at 102 copies per re-
action at 40 °C. This result indicates that there is a
wide dynamic range for quantifying target RNA in
PPRV real-time RT-RPA assay (Fig. 1a and b). The
detection limit of PPRV real-time RT-RPA assay at
95% probability was 102 copies per reaction (probit
analysis, p ≤ 0.05) (Fig. 1c). The specificity of PPRV
real-time RT-RPA assay was determined by cross de-
tection of other viruses which infect epithelium or
mucus in sheep and goat, including FMDV serotypes
O, A and Asia 1, ORFV and capripox virus. No cross
detection was observed, indicating the assay was spe-
cific for PPRV (Table 2).
The developed PPRV real-time RT-RPA assay was
then further tested using samples of PPRV-spiked tis-
sue lysates (n = 18). Results showed that all samples
of the virus-spiked tissues were tested as positive for
PPRV. There were no amplicons detected in the non-
virus-spiked samples despite threshold time being
over 30 min. These results consisted with the results
of PPRV real-time RT-qPCR assay. Both assays
showed the same performance on the samples above,
and a correlation was found between values of the
cycle threshold (RT-qPCR) and threshold time (RT-
RPA) (R squared 0.83, Fig. 2).
Sensitivity and specificity of PPRV LFS RT-RPA assay
To determine the optimal temperature for the RT-
RPA reaction, the ability of the PPRV LFS-RT-RPA
Fig. 1 a Typical raw fluorescence data of real-time RT-RPA assay for
standard RNA in vitro transcribed from the pPPRV/RPA plasmid as they
are shown in the figure. NC represent negative control. b Reproducibility
of the real-time RT-RPA assay. The threshold time is represented
as mean ± standard deviation (SD). The standard regression line
was generated based on 6 data sets (c) Probit regression analysis
using Statistics software (GraphPad Prism 5) was done on data from
the six runs of real-time RT-RPA assay. The limit of detection at 95%
probability is depicted by a triangle
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Table 2 Comparison of PPRV real-time RT-RPA assay and PPRV LFS RT-RPA assay with RT-qPCR assay on virus species, spiked
samples, field samples and healthy sheep samples
Sample type Sample name real-time RT-RPA(min) LFS RT-RPA) RT-qPCR (Cq specific RT-qPCR(Cq)
Virus species PPRV Nigeria 75/1 4.6 + 18 18
GPV AV40 - - - 17
SPV Gulang2009 - - - 19
ORFV/Vaccine/CHA - - - 20
ORFV/HB/CHA - - - 22
FMDV/O/CHA - - - 21
FMDV/A/CHA - - - 19
FMDV/Asia1/CHA - - - 20
Spiked samples Liver 1 4.6 + 16 -
Liver 2 7.6 + 28 -
Liver 3 6 + 20 -
Lungs 1 4.3 + 15
Lungs 2 5.3 + 17 -
Lungs 3 6 + 21 -
Stomach 1 6 + 23 -
Stomach 2 4 + 16 -
Stomach 3 5.3 + 18 -
Kidney 1 5.6 + 21 -
Kidney 2 6 + 24 -
Kidney 3 3.6 + 14 -
Lymphatic nodes 1 5.3 + 17 -
Lymphatic nodes 2 6 + 21 -
Lymphatic nodes 3 4 + 18 -
Skin 1 5.6 + 22 -
Skin 2 6 + 25 -
Skin 3 7.6 + 27 -
Field samples Lung - - - -
Spleen - - - -
Nasal swab - - - -
Kidney - - - -
Spleen 6.3 + 25 -
Nasal swab - - - -
Nasal swab - - -
Kidney - - 31 -
lymphatic nodes - - - -
Nasal swab 6 + 23 -
Kidney - - - -
Spleen 4 + 19 -
Nasal swab - - - -
Lung 5 + 19 -
Spleen - - - -
Kidney - - 33 -
Spleen - - - -
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assay was tested to amplify 104 copies of PPRV RNA
as template at a range of temperatures from 20 °C to
50 °C. Initially, we assessed this range of temperature
under incubation time of 30 min. As shown in Fig. 3a,
no amplification products were observed in reactions
incubated at <37 °C and at 50 °C. There were no dif-
ferences in amplification at 37, 39, 40, 42 and 45 °C
(Fig. 3a). Thus, 39 °C was selected arbitrarily as the
PPRV LFS RT-RPA assay standard temperature. The
performance of the PPRV LFS-RT-RPA assay was
tested at 39 °C incubated for 0, 1, 5, 10, 15, 20, 25
and 30 min. As shown in Fig. 3b, no amplified prod-
ucts were observed in reactions incubated for less
than 10 min and weak amplified product observed for
10 min. When incubation time increased from 15 to
30 min, the assay performance was improved, and
there were no differences in amplification in reactions
incubated between 15 and 30 min, thus 20 min was
selected arbitrarily as the standard incubation time
for PPRV LFS RT-RPA assay. The detection limit of the
PPRV LFS RT-RPA assay was determined using a dilution
series of the cDNA (corresponding to 106 to101 RNA cop-
ies per reaction). The test results showed that the PPRV
LFS RT-RPA assay gave clear positive signal at a concen-
tration of 150 copies per reaction (Fig. 4a), and agarose gel
electrophoresis confirmed the results (Fig. 4b). In evaluat-
ing the specificity of PPRV LFS RT-RPA assay, no cross re-
actions were observed with FMDV serotypes O, A and
Asia 1, ORFV, SPV and GPV (Fig. 5a), which was con-
firmed by the agarose gel electrophoresis (Fig. 5b). The
Fig. 2 Comparison between performances of PPRV real-time RT-RPA
assay and real-time RT-PCR assay on positive samples (n= 14, marked by
balls) and samples of spiked tissues lysates (n= 18, marked by diamonds).
Linear regression analysis of the real-time RT-RPA threshold time (y axis)
and RT-qPCR cycle threshold (Cq) values (x axis) were determined by
Excel software
Table 2 Comparison of PPRV real-time RT-RPA assay and PPRV LFS RT-RPA assay with RT-qPCR assay on virus species, spiked
samples, field samples and healthy sheep samples (Continued)
Lung - - - -
Kidney 5 + 19 -
Nasal swab 7 + 24 -
Spleen 6.3 + 20 -
Lung 6.6 + 22 -
Spleen 5.3 + 20 -
Kidney 6 + 20 -
Spleen 5 + 18 -
Nasal swab 7.3 + 26 -
Kidney 7.6 + 27 -
Spleen 5.6 + 21 -
Lung 6.3 + 22 -
Lymphatic nodes 7.3 + 27 -
Kidney 6.6 + 24 -
Spleen 6 + 23 -
Healthy sheep samples Liver - - - -
Lungs - - - -
Stomach - - - -
Kidney - - - -
Skin - - - -
Samples include PPRV、sheep and goat pox viruses 、foot-and-mouth disease virus and Orf virus, eighteen spiked samples, eighteen filed samples and five
healthy sheep samples. CaPV capripoxvirus, GPV goat pox viruses, SPV sheep pox viruses, CHA China. specific qPCR specific qPCR tested the respective viruses used
in this study, + : positive; - : negative
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specificity of the PPRV LFS RT-RPA assay was further
validated with known positive samples (n = 14) and
negative samples (n = 10) which was confirmed by
PPRV real-time RT-qPCR assay. It was found that
PPRV LFS RT-RPA assay was able to correctly identify
all samples examined. These results indicated that the
PPRV LFS RT-RPA assay were specific for detection of
PPRV.
Performance of PPRV real-time RT-RPA and LFS RT-RPA
assays on clinical samples
Both PPRV real-time RT-RPA and LFS RT-RPA assays
were further evaluated with clinical samples including
thirty-two samples collected from suspected cases of
PPR and five samples from healthy sheep. The results
were then compared with PPRV real-time RT-qPCR
assay. No amplification was detected in five samples ob-
tained from healthy sheep with both PPRV real-time and
LFS RT-RPA assays, even though threshold time (min)
exceeded 30 min. Of 32 samples collected from sus-
pected cases of the PPR, 20 samples were found to be
positive by real-time PPRV RT-qPCR assay (CT value
ranging from 16 to 33). Among these samples, 18 sam-
ples were determined to be positive by both PPRV real-
time RT-RPA assay (threshold time ranging from 5 to
7.6 min) and PPRV LFS RT-RPA assay. The detection
limit of PPRV real-time RT-qPCR assay was 10 copies
per reaction, corresponding to a mean CT value of
34.08, while the detection limit of developed LFS RT-
RPA assay was 150 copies per reaction, corresponding to
a mean CT value of 30.76. For the two samples tested as
negative by both PPRV real-time RT-RPA and LFS RT-
RPA assays, the CT values of RT-qPCR assay values were
33 and 31, respectively, which were beyond the detection
limit of PPRV LFS RT-RPA assay. Based on a total of 37
clinical samples examined, the sensitivity and the specifi-
city of PPRV real-time RT-RPA assay and LFS RT-RPA
assay for identification of PPRV was 90 and 100%, re-
spectively, when compared to PPRV real-time RT-qPCR
(Tables 2 and 3).
Discussion
The developed PPRV real-time RT-RPA and LFS RT-
RPA assays using F2 N/R2 N primer set based on PPRV
N gene sequences could sensitively and specifically de-
tect PPRV present in samples. It is worth mentioning
that maximal running time for the developed RPA assays
is less than 25 min, regardless of the viral concentration
in samples as long as it is above the detection limit (i.e.
> 100 copies per reaction). The results in this study
demonstrated that both developed PPRV real-time RT-
RPA and LFS RT-RPA assays are highly specific for de-
tection of PPRV as there is no cross reaction with GPV,
SPV, FMDV and ORFV, which may cause similar clinical
signs to PPRV in small ruminants, indicating the poten-
tial possibility of being a novel testing tool for differen-
tial diagnosis. Its high specificity for detection of PPRV
is due to the fact that RPA uses specific detection
probes, like real-time qPCR assay does. Although the
sensitivity of RPA is lower than RT-qPCR, some
a b
Fig. 4 a The sensitivity of LFS RT-RPA was 150 copies of the standard plasmids transcribed RNA, b and all the LFS RT-RPA positive result could be
consolidated on stained agarose gel (2%) assay
a b
Fig. 3 Determination of reaction temperature and time. a The LFS RT-RPA assay were performed respectively at different temperatures as they
are shown in the figure. b After 10 min of isothermal amplification reaction, the slight test line is visible on the test strip, and when the amplification
time is longer than 15 min or 20 min, the clear test line is visible on the test strip. Including the incubation time of 2 min, the whole assay time of the
LFS RT-RPA assay is less than 25 min, and the results showed that this assay works effectively in a broad range of temperatures from 37 to 45 °C
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advantages of the RT-RPA assay over RT-qPCR assay
make it attractive. Firstly, reaction mixtures are pre-
made pellets and provided in vacuum-sealed pouches,
which can be kept at room temperatures for several
days. This would save on cooling costs and facilitate
onsite diagnosis of PPR in the field. Secondly, the reac-
tion can be performed in a water bath at temperature of
37 °C to 45 °C for 20 min. Thirdly, RPA supplies differ-
ent kinds of end-point detection formats (such as Twist
Amp® basic kit, Twist Amp® exo kit and Twist Amp® nfo
kit) that could be adapted by different laboratories,
therefore making RPA adaptable in a well-equipped la-
boratory, a mobile laboratory or a rural area where ex-
pensive diagnostic instrument is not available.
Like RT-LAMP assay, RT-RPA reaction could also be
performed using a water bath and the reaction results
could be directly distinguished through LFS device by
the naked eye. However, the developed RT-RPA assay
was faster than RT-LAMP assay (within 20 min in RT-
RPA assay while 60 min in RT-LAMP assay). Moreover,
RT-RPA assay requires one pair of primers combined
with a probe and lower temperature (39 °C), while RT-
LAMP needs at least three pairs of primers and higher
temperature (62 °C). However, as a relatively novel tech-
nology RPA has not been used in field diagnostics yet. Like
other molecular assays including LAMP [22, 25, 26], RNA
used in the RPA assay has been extracted from samples
which are laborious and time-consuming. To achieve as a
pen-site molecular diagnostic tool, there is a need to sim-
plify RNA or DNA extraction. We have successfully used
a commercially available innuPREP MP basic kit A (Jena
Analytik, Jena, Germany) and a magnetic bead separation
rack combined with proteinase K to extract nucleic acids
from all samples. The extracted nucleic acids could be
directly used in the PCR assay and RPA assay. Our test re-
sults with the 32 clinical samples, as described above,
using the innuPREP MP basic kit A showed the same per-
formance in both RT-RPA assay and RT-qPCR assay when
compared with the High Pure Viral Nucleic Acid kit
(Roche, Germany). At the moment, PPRV RPA assay is
still costlier than LAMP assay and RT-qPCR assay, but
RPA has a few unique advantages as described above. As
the technology develops and becomes widely used for
diagnosis of disease, the cost of RPA should gradually
drop. In fact, we have successfully reduced the cost by
simple reduction of reaction volume from the original
50 μL volume to 25 μL.
Conclusions
PPRV real-time RT-RPA and LFS RT-RPA assays described
are sensitive and specific for rapid detection of PPRV within
less than 20 min. Evaluation using extracted RNA from
clinical samples demonstrated both assay have about 90%
sensitivity and 100% specificity when compared to PPRV
Table 3 Performance of the real-time RT-RPA assay or LFS RT-RPA assay in comparison with the real-time RT-qPCR assay for detect-
ing PPRV on clinical samples
Real-time qPCR Performance characteristics (%)
Positive Negative Sensitivity Specificity
Real-time RPA Positive 18 0 90% 100%
Negative 2 17
Total (n = 37) 20 17
RPA LFD Positive 18 0 90% 100%
Negative 2 17
Total (n = 37) 20 17






Fig 5 Specificity test results of LFS RT-RPA assay using total DNA/RNA extracted from PPR virus and other virus. PPRV: peste des petits ruminants,
ORFV: Orf virus, GPV: goat pox viruses, SPV: sheep pox viruses, FMDV: foot-and-mouth disease virus. a Positive RPA nfo reaction products can be
detect in the lateral flow strips format (LFS RT-RPA). b Positive RPA nfo reaction products (121 bp) also can be detect on a stained agarose gel (2%)
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real-time RT-qPCR assay. The results are encouraging but
the assays need to be further validated by analysis of a lar-
ger number of samples from animals infected with PPRV
and with isolates of different PPRV lineages II, III, IV before
such an assay can be considered for routine diagnostic use.
Additional file
Additional file 1: Figure S1. Three forward primes (Fe1 N to Fe3 N),
three reverse primers (Re1 N to Re3 N) and one probe (Pe) were tried to
screen the best combination yielding the highest amplification. The
amplification results of nine different combinations were shown in the
figure. (PPTX 126 kb)
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LFS RT-RPA assay: Reverse transcription recombinase polymerase
amplification assay combination with a lateral flow strip; PPRV: Peste des
petits ruminants virus; real-time RT-RPA assay: Reverse transcription
recombinase polymerase amplification assay using real-time fluorescent de-
tection; RPA: Recombinase polymerase amplification; RT-LAMP: Reverse
transcription loop-mediated isothermal amplification; RT-qPCR: Reverse
transcription quantitative PCR
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